Although the 2023 clinical trial landscape has had a rocky few years, a number of innovative new drugs have still made it to market.From the first success in a Phase III CRISPR trial to another Alzheimer’s disease drug showing efficacy in disease progression, 2023 has been a notable year for clinical trials.According to GlobalData’s Pharmaceutical […]